Express Scripts Holding (NASDAQ:ESRX) – Research analysts at Leerink Swann cut their Q1 2018 earnings per share (EPS) estimates for shares of Express Scripts in a research report issued to clients and investors on Wednesday, according to Zacks Investment Research. Leerink Swann analyst D. Larsen now forecasts that the company will post earnings of $1.75 per share for the quarter, down from their prior estimate of $1.86.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.09 by $0.07. The company had revenue of $25.38 billion for the quarter, compared to analyst estimates of $25.07 billion. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. Express Scripts’s revenue was up 2.1% compared to the same quarter last year. During the same period last year, the company posted $1.88 earnings per share.
Several other equities analysts have also issued reports on ESRX. Deutsche Bank started coverage on shares of Express Scripts in a report on Monday, December 4th. They set a “buy” rating and a $75.00 price objective on the stock. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, December 4th. TheStreet raised shares of Express Scripts from a “c+” rating to a “b-” rating in a report on Monday, December 4th. Sanford C. Bernstein raised shares of Express Scripts from an “underperform” rating to a “market perform” rating in a report on Wednesday, December 6th. Finally, BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Thursday, December 14th. Three equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and six have given a buy rating to the stock. Express Scripts currently has a consensus rating of “Hold” and a consensus price target of $81.97.
Shares of Express Scripts (ESRX) traded down $0.24 during mid-day trading on Monday, reaching $76.76. 7,107,170 shares of the company traded hands, compared to its average volume of 5,314,345. The stock has a market capitalization of $43,220.00, a price-to-earnings ratio of 9.90, a price-to-earnings-growth ratio of 0.96 and a beta of 0.94. The company has a current ratio of 0.67, a quick ratio of 0.55 and a debt-to-equity ratio of 0.83. Express Scripts has a 12 month low of $55.80 and a 12 month high of $85.07.
Several institutional investors and hedge funds have recently made changes to their positions in ESRX. SeaCrest Wealth Management LLC acquired a new position in Express Scripts during the fourth quarter valued at $105,000. Aevitas Wealth Management Inc. acquired a new position in Express Scripts during the fourth quarter valued at $128,000. Financial Gravity Companies Inc. acquired a new position in Express Scripts during the fourth quarter valued at $142,000. Bank of Nova Scotia Trust Co. acquired a new position in Express Scripts during the third quarter valued at $120,000. Finally, Monroe Bank & Trust MI lifted its position in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after purchasing an additional 970 shares during the period. 89.08% of the stock is currently owned by hedge funds and other institutional investors.
In other news, VP Christine Houston sold 10,104 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares of the company’s stock, valued at $6,124,992. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Glen D. Stettin sold 3,448 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. Insiders have sold 21,896 shares of company stock worth $1,617,903 over the last three months. Corporate insiders own 0.68% of the company’s stock.
Express Scripts declared that its board has initiated a share repurchase plan on Monday, December 18th that allows the company to buyback 45,000,000 shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its stock is undervalued.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.